Project 3. Therapeutic potential of myosin Regulatory Light Chain (RLC) phosphorylation in treatment of heart disease
Genetic cardiomyopathies are the most prevalent inherited heart diseases and no therapies are currently available to cure or delay progression from hypertrophy to heart failure, and/or to prevent sudden cardiac death. Thus, efforts must be undertaken to develop new and effective therapeutic strategies. In this research project we aim to explore the therapeutic potential of the pseudo-phosphorylated […]